Gilead Gives $20 Million to Prevent Closure of LGBTQ and HIV-Prevention Nonprofits

The Truvada manufacturer's new emergency grant fund will go to groups facing shutdown

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Coinciding with Friday’s National Youth HIV and AIDS Awareness Day, pharma giant Gilead announced the creation of a new global $20 million fund to help keep struggling healthcare and LGBTQ nonprofits open.

Gilead CARES (COVID-19 Acute Relief and Emergency Support) is the latest financial support initiative from the company best known for manufacturing Truvada, the widely used HIV antiviral drug taken daily by thousands to prevent infection.

The $20 million will take the form of grants to nonprofit organizations already supported by Gilead, like its 139 partners across the southern U.S.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in